
iPremom's €15M Bet on First-Trimester Preeclampsia Detection
iPremom (Spain) — Valencia molecular diagnostics startup closes €15M seed led by Amadeus Capital to advance its MaiRa platform, which detects preeclampsia risk from a simple blood test taken as early as 9 weeks into pregnancy.



